VTAK VS OTRK Stock Comparison

PerformanceAnalyst Price TargetsEarningsVolatilityTechnicalsProfitDividend
PerformanceAnalyst Price TargetsEarningsVolatilityTechnicalsProfitDividend

Performance

VTAK
10/100

VTAK returned -27.27% in the last 12 months. Based on SPY's performance of 15.17%, its performance is below average giving it a score of 10 of 100.

OTRK
10/100

OTRK returned -76.21% in the last 12 months. Based on SPY's performance of -13.42%, its performance is below average giving it a score of 10 of 100.

Analyst Price Targets

VTAK
75/100

4 analysts offer 12-month price targets for VTAK. Together, they have an average target of 0, the most optimistic target put VTAK at 0 within 12-months and the most pessimistic has VTAK at 0.

OTRK

"Analyst Price Targets" not found for OTRK

Earnings

VTAK
100/100

VTAK has missed earnings 0 times in the last 20 quarters.

OTRK
14/100

OTRK has missed earnings 3 times in the last 20 quarters.

Volatility

VTAK
48/100

VTAK has had a lower than average amount of volatility over the last 12 months giving it a score of 47 of 100.

OTRK
51/100

OTRK has had a higher than average amount of volatility over the last 12 months giving it a score of 50 of 100.

Technicals

VTAK

"Technicals" not found for VTAK

OTRK
11/100

OTRK receives a 10 of 100 based on 14 indicators. 1 are bullish, 12 are bearish.

Profit

VTAK

"Profit" not found for VTAK

OTRK
10/100

Out of the last 20 quarters, OTRK has had 0 profitable quarters and has increased their profits year over year on 0 of them.

Dividend

VTAK

"Dividend" not found for VTAK

OTRK
10/100

OTRK's most recent dividend was $0.43 per share, based on a share price of $0.69. It was a payout ratio of -23.79% compared to their total earnings.

All score calculations are broken down here to help you make more informed investing decisions

Catheter Precision, Inc. Summary

Healthcare
Medical - Devices
Catheter Precision, Inc. develops and delivers electrophysiology products to provide patients, hospitals, and physicians with technologies and solutions to improve the lives of patients with cardiac arrhythmias in the United States. The company's lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. It also provides LockeT, a suture retention device; and Amigo Remote Catheter System, a robotic arm that serves as a catheter control device. The company was formerly known as Ra Medical Systems, Inc and changed its name to Catheter Precision, Inc. in August 2023. Catheter Precision, Inc. is based in Fort Mill, South Carolina.

Ontrak, Inc. Common Stock Summary

Nasdaq / OTRK
Healthcare
Medical - Healthcare Information Services
Ontrak, Inc. operates as an artificial intelligence powered, telehealth-enabled, and virtualized healthcare company that provides in-person services to health plans and other third-party payors in the United States. Its technology-enabled platform predicts people whose chronic disease will improve with behavior change, recommends effective care pathways that people are willing to follow, and engages and guides them to and through the care they need. The company's technology-enabled OnTrak program provides healthcare solutions to members with behavioral conditions that cause or exacerbate chronic medical conditions, such as diabetes, hypertension, coronary artery disease, chronic obstructive pulmonary disease, and congestive heart failure. The OnTrak integrates evidence-based psychosocial and medical interventions delivered in-person or via telehealth along with care coaching and in-market community care coordinators, who address the social and environmental determinants of health. The company was formerly known as Catasys, Inc. and changed its name to Ontrak, Inc. in July 2020. The company was incorporated in 2003 and is headquartered in Henderson, Nevada.